Multiple Myeloma Research Consortium Opens Record-Breaking Number of Trials in 2011 to Advance Multiple Myeloma Treatments

Published: Dec 22, 2011

NORWALK, Conn.--(BUSINESS WIRE)--The Multiple Myeloma Research Consortium (MMRC) today announced that it opened more multiple myeloma clinical trials at its member institutions during 2011 than any other year since the Consortium was founded in 2004. This highly successful year is the culmination of joint efforts by the MMRC, its members and its pharmaceutical and biotech partners to rapidly advance treatment options for patients with multiple myeloma, an incurable blood cancer.

Back to news